中医药在宫颈癌管理中的作用
本文综述中医药在宫颈癌治疗中的研究进展,涉及桂枝茯苓丸、复方阳和颗粒、黄芪、人参及人参皂苷Rh2、丹参酮IIA、汉防己甲素等中药单体与复方;并报告一例晚期宫颈癌多发腹盆腔转移患者先化疗后单纯中医药治疗生存22年的案例。
要点
- 晚期宫颈癌预后极差,5年无进展生存率仅15%。
- 中医药可能增强化疗敏感性、强化抗肿瘤效应并改善疲乏和骨髓抑制。
- 全程中医药管理模式或可延长部分癌症患者生存期。
核心结论
- 中医药在宫颈癌治疗中可能增强化疗敏感性、强化抗肿瘤效应并改善癌因性疲乏和骨髓抑制等不良反应。
- 全程中医药管理模式可能使更多癌症患者获得更长生存期。
研究设计与样本
- 本文为综述,汇总中药复方、中药单体及提取物治疗宫颈癌的研究进展,并报告一例晚期宫颈癌患者个案。
主要发现
- 晚期宫颈癌预后极差,5年无进展生存率仅15%。
- 中国宫颈癌发病率在女性恶性肿瘤中居第二位,仅次于乳腺癌。
- 桂枝茯苓丸、复方阳和颗粒、黄芪、人参、人参皂苷Rh2、丹参酮IIA和汉防己甲素等受到广泛关注。
- 一例晚期宫颈癌伴多发腹盆腔转移患者先接受化疗、后单纯中医药治疗,生存22年。
临床怎么用
- 在宫颈癌全程管理中可考虑整合中医药以辅助增效减毒,但需基于个体化评估。
局限性
- 本文为综述并附个案报告,未提供随机对照试验等高质量证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Globally, cervical cancer poses a substantial public health challenge, with low and middle-income countries bearing the highest burden [Rajkhowa, P., D.S. Patil, S.M. Dsouza, P. Narayanan and H. Brand. Evidence on factors influencing HPV vaccine implementation in South Asia: a scoping review. Glob. Public Health 18: 2288269, 2023]. The incidence rate ranks second highest among female malignant tumors in China, following only breast cancer. The prognosis of advanced cervical cancer is extremely poor, with a 5-year progression-free survival (PFS) rate of only 15%, and the treatment of advanced recurrent or metastatic cervical cancer remains a huge challenge. An increasing amount of evidence suggests that traditional Chinese medicine (TCM) can significantly enhance sensitivity to chemotherapeutic drugs, strengthen antitumor effects, and notably improve adverse reactions associated with cancer such as fatigue and bone marrow suppression. In recent years, the therapeutic effects and mechanisms of Chinese herbal medicines, such as the Guizhi-Fuling-decoction, the compound Yangshe granule, Huangqi, and Ginseng, herbal monomers (e.g., Ginsenoside Rh2, Tanshinone IIA, and Tetrandrine), and the related extracts and compound formulations, have received extensive attention for the treatment of cervical cancer. This paper reviews the research progress of TCM in cervical cancer. In addition, we reported a case of an advanced cervical cancer patient with multiple abdominal and pelvic metastasis who initially received chemotherapy, was then treated with TCM alone, and subsequently survived for 22 years. The model of whole-process management with TCM can enable more cancer patients to obtain longer survival periods.
引用
- Wu D, Zhou R, Chen H, et al. The Role of Traditional Chinese Medicine in the Management of Cervical Cancer. Am J Chin Med. 2024. PMID: 38790084. doi:10.1142/S0192415X24500411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。